Purpose of the Test
- Monitoring tumor burden and activity in the body.
- Detecting genetic mutations causing treatment resistance.
- Evaluating the efficacy of chemotherapy or radiation.
Monitor tumor activity and detect genetic mutations early with advanced liquid biopsy. This non-invasive test helps your doctor refine treatment plans accurately, ensuring the most effective management of your health journey.
Scientific name: Liquid Biopsy for Cancer Monitoring (cfDNA)
An advanced blood test measuring cell-free DNA (cfDNA) to monitor tumor burden, track response to chemotherapy or immunotherapy, and detect genetic mutations that may lead to drug resistance.